<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1881">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04625257</url>
  </required_header>
  <id_info>
    <org_study_id>2020-01112; ch20Savic2</org_study_id>
    <nct_id>NCT04625257</nct_id>
  </id_info>
  <brief_title>COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)</brief_title>
  <official_title>COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ETH Zurich Department for Biosystems, Science and Engineering</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kanton Basel- Landschaft</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to establish an accurate, robust and easily scalable COVID-19 viral nucleic&#xD;
      acid analysis platform from, but not limited to, saliva to help enable and support contact&#xD;
      tracing in the canton of Baselland/ Switzerland. To achieve this, crude ribonucleotide acid&#xD;
      (RNA) extraction from saliva is validated in combination with next-generation sequencing&#xD;
      (NGS) diagnostics and loop mediated amplification (LAMP) assays as well as point of care test&#xD;
      (POCT) for rapid detection of viral antigens on patients' samples.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 24, 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>qualitative method validation of the crude extraction in combination with the LAMP or the NGS (count values for detection)</measure>
    <time_frame>single point assessment at baseline</time_frame>
    <description>For all qualitative method validation, the qualitative and quantitative result of the Foederatio Analyticorum Medicinalium Helveticorum (FAMH) performed RT-PCR (patient does / does not have SARS-Cov-2 and if yes, how many &quot;ct&quot; values for detection) is considered as the gold standard against which the crude extraction in combination with the LAMP or the NGS method using univariate measures is compared.</description>
  </primary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Coronavirus Infectious Disease 2019 (COVID-19)</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saliva based assay: crude RNA extraction</intervention_name>
    <description>Crude RNA extraction to inactivate the virus and stabilize the RNA for transport at room temperature. Validation of the crude RNA extraction from saliva in combination with NGS diagnostics and LAMP assays and point of care test (POCT) for rapid detection of viral antigens on patients' samples.</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Validation of the NGS method</intervention_name>
    <description>Compare the results obtained with the next-generation sequencing (NGS) method to the nasopharyngeal swabs analysed in a FAMH certified lab.</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Validation of the LAMP assays</intervention_name>
    <description>The RNA will be analyzed onsite using the loop mediated amplification (LAMP) assay.</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Validation of the POCT Antigen tests</intervention_name>
    <description>Rapid point of care antigen tests (POCT) detecting viral protein antigens (Ag) using specific antibodies. POCT are often employed in low income countries, but for COVID-19 they are not yet characterized. Their performance is to be characterized that they can be used as a safe guard if the lab diagnostics fail.</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biological material is appropriately stored in a restricted area only accessible to&#xD;
      authorized personnel. Until completion of the study, the material will be stored in the&#xD;
      biobank &quot;SERO-BL-COVID-19&quot;.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Symptomatic patients arriving at the COVID-19 test center Spenglerpark in Muenchenstein/&#xD;
        Switzerland to get tested for COVID-19&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  symptomatic patients getting tested for COVID-19&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  mentally incompetent adults&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miodrag Savic, Dr. med. Dr. med. dent.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cantonal Office of Public Health, Economics and Health Directorate, Canton Basel-Landschaft</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miodrag Savic, Dr. med. Dr. med. dent.</last_name>
    <phone>+41 79 485 31 13</phone>
    <email>miodrag.savic@usb.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cantonal Office of Public Health, Economics and Health Directorate, Canton Basel-Landschaft</name>
      <address>
        <city>Liestal</city>
        <zip>4410</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miodrag Savic, Dr. med. Dr. med. dent.</last_name>
      <phone>+41 79 485 31 13</phone>
      <email>miodrag.savic@usb.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 10, 2020</study_first_submitted>
  <study_first_submitted_qc>November 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 12, 2020</study_first_posted>
  <last_update_submitted>November 11, 2020</last_update_submitted>
  <last_update_submitted_qc>November 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)</keyword>
  <keyword>quantitative reverse transcription polymerase chain reaction (qRT-PCR) assay</keyword>
  <keyword>point of care tests (POCT)</keyword>
  <keyword>next-generation sequencing (NGS) method</keyword>
  <keyword>contact tracing</keyword>
  <keyword>transmission chains</keyword>
  <keyword>crude RNA extraction from saliva</keyword>
  <keyword>loop mediated amplification (LAMP) assay</keyword>
  <keyword>viral nucleic acid analysis platform</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

